Log In
BCIQ
Print this Print this
 

DTX601

  Manage Alerts
Collapse Summary General Information
Company Dimension Therapeutics Inc.
Description Adeno-associated viral (AAV) vector delivering argininosuccinate synthase 1 (ASS; ASS1)
Molecular Target Argininosuccinate synthase 1 (ASS) (ASS1)
Mechanism of Action 
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentDiscovery
Standard IndicationUrea cycle disorder (UCD)
Indication DetailsTreat citrullinemia type I
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today